Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Mysimba 8 mg/90 mg prolonged-release tablets {equilateral_black_triangle}

Active Ingredient:
naltrexone hydrochloride, bupropion hydrochloride
Orexigen Therapeutics Ireland Limited See contact details
ATC code: 
About Medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
Last updated on emc: 31 Oct 2023

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

Orexigen Therapeutics Ireland Limited
Company image
2nd Floor, Palmerston House, Dublin 2, Ireland
Medical Information Direct Line
Medical Information e-mail
[email protected]
Customer Care direct line
Medical Information Fax
+44 203 905 2657